CD2 and cancer: Transwell migration and invasion assays confirmed that MDA‐MB‐231 cells cocultured with sh‐CD2 CTLs exhibited significantly higher migration and invasion abilities than those cocultured with CTL or sh‐NC CTL cells (Figure 4D), suggesting that CD2‐deficient CTLs may promote malignant tumor progression by reducing immune surveillance.